NFE2L2 and cancer: In fact, the Keap1–Nrf2 antioxidant system, which comprises also Dpp3 among its activators, is known to exert both protective and detrimental effects, in cancer [4] as well as in bone biology, acting both on the osteoclast and on the osteoblast lineage [26].